Total Funding
9
26
Total FundingConvertible Note raised
Growth Score 9 in past quarter
-11 pts
Heat Score 26 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
478792
Qrono, Inc. is a biotechnology corporation that develops therapies for treating cancer tumours.
About the Company
Qrono discovers and develops immunotherapy drug products targeting antigen presenting cells to enhance vaccines and cure autoimmune diseases. They engage in the development of patentable nanomedicines intended to reprogram antigen-presenting cells in cancer and other diseases.
